Hematology & Oncology
451 - 465 of
566 Results
Sort Results:
Article:
More women with EARLY breast cancer will be treated with an aromatase inhibitor
January 2005
Article:
Tarceva (erlotinib), a new ORAL treatment for non-small cell lung cancer (NSCLC)
January 2005
Other:
New Evidence Supports the Third-generation Aromatase Inhibitor Exemestane (Aromasin) for Primary Breast Cancer
April 2004